Dr Andrew Nash

Director since 2025.

PhD (Immunology) – University of Melbourne.

• 2021–present: Fellow, Australian Academy of Technological Sciences and Engineering
• 2016–present: Advisory Board Member, Gene Technology Access Centre
• 2008–present: Board Member, Oral Health CRC
• 2014–2024: Board Member, Research Australia.

• Honorary Appointment, Principal Fellow and Associate Professor, Bio21 Institute, The University of Melbourne
• Former Chief Scientific Officer and Senior Vice-President (Research), CSL Limited
• Former Chief Executive Officer, Zenyth Therapeutics.